Check out our latest customer video, showcasing the use of our medical device during medical procedures at Medway NHS Foundation Trust

   Check out our appearance on the BBC, showcasing the use of our medical device at Worcestershire Royal Hospital

Check out our appearance on the BBC, showcasing the use of our medical device at Worcestershire Royal Hospital

All our use cases > Oncology

Oncology

Indications

Use of virtual reality on an anxious child during a puncture in oncology

                                            Clinical studies

Clinical studies

Clinical study published in the palliative_& supportive care journal
-93% -42%
PAIN ANXIETY

Virtual reality used as a distraction for pain and anxiety in breast cancer patients, Palliative and Supportive Care Journal, 2019

Bani Mohammad E. & Ahmad M.

Results: The independent sample t-test showed a significant difference after the pain intervention. The mean of the intervention group was 0.33 (SD = 0.82), and that of the control group was 4.84 (SD = 2.57) (t = -9.19, p < 0.001). The anxiety test showed a significant difference after the intervention between the two groups. The mean of the intervention group was 37.68 (SD=3.80); the mean of the control group was 50.13 (SD=9.32) (t=-7.83, p<0.001).  N=80

Clinical study published in a journal of psychology
-72% -44% -59%
INCONFORT MAXIMUM PAIN TIME THOUGHT TO PAIN

Virtual reality analgesia during venipuncture in paediatric patients with onco-haematological diseases, Frontiers in Psychology, 2018

Atzori B., et al.

Results: During venipuncture, patients’ average pain level was significantly lower during VR for all three pain components:

  • “Time spent thinking about pain” during “No VR” mean = 3.23 (SD = 2.98) vs. “Yes VR” mean = 1.33 (SD = 1.05), p < 0.05, Cohen’s d = 0.62, moderate effect size;
  • “Inconvenience pain-related of pain” during “No VR” mean = 3.27 (SD = 3.43) vs. during “Yes VR” mean = 0.93 (SD = 1.16), p < 0.01, Cohen’s d = 0.70, moderate effect size;
  • “Worst pain felt” during “No VR” mean = 3.60 (SD = 3.00) vs. during “Yes VR” mean = 2.00 (SD = 1.20), p < 0.05, Cohen’s d = 0.51, moderate effect size.

Results: During venipuncture, patients’ average pain level was significantly lower during VR for all three pain components:

– “Time spent thinking about pain” during “No VR” mean = 3.23 (SD = 2.98) vs. “Yes VR” mean = 1.33 (SD = 1.05), p < 0.05, Cohen’s d = 0.62, moderate effect size;

– “Inconvenience pain-related of pain” during “No VR” mean = 3.27 (SD = 3.43) vs. during “Yes VR” mean = 0.93 (SD = 1.16), p < 0.01, Cohen’s d = 0.70, moderate effect size;

– “Worst pain felt” during “No VR” mean = 3.60 (SD = 3.00) vs. during “Yes VR” mean = 2.00 (SD = 1.20), p < 0.05, Cohen’s d = 0.51, moderate effect size.

Testimonies

References